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Abstract There is sparse information about speciﬁc
storage and handling protocols that minimize analytical
error and variability in samples evaluated by targeted
metabolomics. Variance components that affect quantita-
tive lipid analysis in a set of human serum samples were
determined. The effects of freeze-thaw, extraction state,
storage temperature, and freeze-thaw prior to density-based
lipoprotein fractionation were quantiﬁed. The quantiﬁcation
of high abundance metabolites, representing the biologi-
cally relevant lipid species in humans, was highly repeat-
able (with coefﬁcients of variation as low as 0.01 and 0.02)
and largely unaffected by 1–3 freeze-thaw cycles (with
0–8% of metabolites affected in each lipid class). Extraction
state had effects on total lipid class amounts, including
decreased diacylglycerol and increased phosphatidyletha-
nolamine in thawed compared with frozen samples. The
effects of storage temperature over 1 week were minimal,
with 0–4% of metabolites affected by storage at 4C,
-20C, or -80C in most lipid classes, and 19% of
metabolites in diacylglycerol affected by storage at -20C.
Freezing prior to lipoprotein fractionation by density
ultracentrifugation decreased HDL free cholesterol by 37%
and VLDL free fatty acid by 36%, and increased LDL
cholesterol ester by 35% compared with fresh samples.
These ﬁndings suggest that density-based fractionation
should preferably be undertaken in fresh serum samples
because up to 37% variability in HDL and LDL cholesterol
could result from a single freeze-thaw cycle. Conversely,
quantitative lipid analysis within unfractionated serum is
minimally affected even with repeated freeze-thaw cycles.
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Abbreviations
TC Total cholesterol
TG Triacylglycerol
FA Fatty acid
DG Diacylglycerol
FFA Free fatty acid
GC Gas chromatography
PC Phosphatidylcholine
LY Lysophosphatidylcholine
PE Phosphatidylethanolamine
CE Cholesterol ester
SFA Saturated fatty acid
MUFA Monounsaturated fatty acid
PUFA Polyunsaturated fatty acid
CV Coefﬁcient of variation
FC Free cholesterol
dm Dimethyl
1 Introduction
Improper storage and handling of serum samples prior to
compositional analysis by targeted metabolomics and
A. M. Zivkovic  J. B. German (&)
Department of Food Science and Technology, University
of California, 1 Shields Ave., Davis, CA 95616, USA
e-mail: jbgerman@ucdavis.edu
M. M. Wiest  U. T. Nguyen  R. Davis  S. M. Watkins
Lipomics Technologies, Inc., West Sacramento, CA 95691, USA
J. B. German
Nestle ´ Research Center, Lausanne, Switzerland
123
Metabolomics (2009) 5:507–516
DOI 10.1007/s11306-009-0174-2lipoprotein separation may signiﬁcantly inﬂuence accuracy
compared with the analysis of fresh samples. Yet there is
little information about speciﬁc storage conditions and
handling protocols that can minimize error and variability.
The only literature available examines the effects of sample
storage and handling on the enzymatic analysis of total
cholesterol (TC) and triacylglycerol (TG). The results of
these experiments have been mixed. In some studies,
freezing and storage time increased lipid concentrations
(Evans et al. 1997; Pini et al. 1990; Tiedink and Katan
1989; Wood et al. 1980); in other studies, lipid concen-
trations decreased (Bausserman et al. 1994; Donnelly et al.
1995; Ekbom et al. 1996; Evans et al. 1995, 1997; Nanjee
and Miller 1990; Simo et al. 2001; Tiedink and Katan
1989); and other studies found either increases or decreases
depending on initial concentrations (Bachorik et al. 1980,
1982). Still other investigators found no signiﬁcant changes
in lipid concentration (Bausserman et al. 1994; Donnelly
et al. 1995; Kuchmak et al. 1982; Nanjee and Miller 1990;
Stokes et al. 1986; Wood et al. 1980). Only two studies
examined the effects of multiple freeze-thaw cycles.
Samples that were stored for 24 months at -80C and that
had undergone 1–3 freeze-thaw cycles showed composi-
tional changes after 24 months as analyzed with enzymatic
detection kits (Kronenberg et al. 1994), but there were no
differences between 1 and 3 freeze-thaw cycles. Another
study also found no differences, but freeze-thawed samples
were compared only with each other and not with fresh
samples (Comstock et al. 2001).
To our knowledge there is no information regarding the
storage and handling of serum samples and their effects on
the composition of fatty acids (FA) within separated lipid
classes as measured by quantitative lipid analysis, within
whole serum or density fractionated serum. Therefore, the
aims of this study were to examine in detail the storage and
handling conditions that inﬂuence the quality of lipid
compositional analyses using a combination of platforms,
including preparative HPLC and TLC, and gas chroma-
tography (GC)-ﬂame ionization detection (FID). In par-
ticular, we sought to determine the effects of multiple
freeze-thaw cycles, the state of the sample (frozen or
thawed) at the time of extraction, storage temperature, and
freezing serum prior to lipoprotein fractionation on quan-
titative lipid analysis in human samples.
2 Materials and methods
Two experiments were performed to investigate the overall
effects of sample storage and handling. For Experiment 1,
samples were purchased from PromedDx (Norton, MA),
and for Experiment 2, fresh serum samples were collected
from a healthy volunteer after an overnight fast. Methods,
experimental design, and statistical analyses speciﬁc to
each experiment are described below.
2.1 Quantitative lipid analysis
In both Experiment 1 and Experiment 2, quantitative lipid
analysis was performed by Lipomics Technologies, Inc.
(West Sacramento, CA) according to the method of
Watkins et al. (2002). Brieﬂy, lipids were extracted in the
presence of authentic internal standards by the method
of Folch et al. (1957) using chloroform-methanol (2:1,
v/v) ? 0.05% butylated hydroxytoluene. Serum (200 ll)
was used for each analysis. Individual lipid classes—TG,
diacylglycerol (DG), free fatty acids (FFA), phosphatidyl-
choline (PC), lysophosphatidylcholine (LY), phosphati-
dylethanolamine (PE), cholesterol ester (CE), and free
cholesterol (FC)—within each extract were separated by
preparative HPLC (Cao et al. 2008) for the phospholipid
classes and by thin-layer chromatography for the neutral
lipid classes. Each isolated lipid class fraction (except FC,
as this lipid class contains no FA) was trans-esteriﬁed in
3 N methanolic-HCl in a sealed vial under N2 at 100C for
60 min. The resulting FA methyl esters were extracted
from the mixture with hexane containing 0.05% butylated
hydroxytoluene and prepared for GC by sealing the hexane
extracts under N2. FA methyl esters were separated and
quantiﬁed by capillary GC using a gas chromatograph
(Agilent Technologies model 6890, Wilmington, DE)
equipped with a 30-m DB-225MS capillary column (Agi-
lent Technologies, Folsom, CA) and a ﬂame-ionization
detector. A total of 37 FA were measured in each lipid
class and included the following: 14:0, 15:0, 16:0, 18:0,
20:0, 22:0, 24:0, 14:1n5, 16:1n7, trans (t)16:1n7, 18:1n9,
t18:1n9, 18:1n7, 18:2n6, t18:2n6, 18:3n6, 18:3n3, 18:4n3,
20:1n9, 20:2n6, 20:3n9, 20:3n6, 20:4n6, 20:3n3, 20:4n3,
20:5n3, 22:1n9, 22:2n6, 22:4n6, 22:5n3, 22:6n3, 24:1n9,
and 24:6n3, and the plasmalogen derivatives of 16:0, 18:0,
18:1n9, and 18:1n7.
2.2 Data processing and statistics
The determined amounts of individual FA were used to
calculate the mass of individual lipid classes, which were
expressed as nmol FA/g serum. Individual FA data were
analyzed as mol.% calculated as the percentage of each
individual FA relative to the sum of the concentrations of
all FA within that lipid class. Lipid class composition was
analyzed as both individual FA concentrations and as cat-
egories of FA: SFA, saturated; MUFA, monounsaturated;
PUFA, polyunsaturated; and n3, n6, n7, and n9: omega-3,
-6, -7, and -9, respectively. The data were pre-processed
before formal statistical methods were applied in order to
account for the large data density of metabolomic analyses.
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123Metabolites with [30% missing observations were
excluded, and observations that were [4 standard devia-
tions from the mean were excluded for statistical analysis
after lipid class totals were calculated.
Change detection plots were used to determine whether
the observed signal was greater than that which could be
expected by chance (noise). Change detection plots were
produced in the following way: P-values for the appro-
priate comparison were calculated for each metabolite
using a Student’s t-test and ranked from smallest to largest.
The log of the rank versus the log of the P value for each
comparison of interest was plotted. The distribution of
P-values expected by chance at each rank was determined
by a Monte Carlo permutation method, using values for
each group that had been scaled to the mean and combined.
The Nth ranked P-values from many permutations were
used to construct the Nth boxplot. The y-axis value at
which each rank versus log P-value line intercepts the
vertical line indicates how many observed P-values
exceeded the smallest P-value expected by chance.
Data were assessed for normality with histograms. If
non-normality was detected, a log transformation was
performed and the data were then re-analyzed. The results
(P-values) of the log-transformed data were similar to the
results of the non-transformed data, therefore the non-
transformed data were used for analysis and reporting.
All statistics were performed using the software pro-
gram R (The R Foundation for Statistical Computing).
2.3 Experiment 1: study design, methods, and statistics
The hypothesis was that multiple freeze-thaw cycles, pre-
extraction state (frozen or thawed), and storage temperature
lead to changes in FA concentrations within serum sam-
ples. The speciﬁc aims of this experiment were to deter-
mine the effects of these three key factors. (1) The effect of
the number of freeze-thaw cycles was determined by
comparing fresh samples with samples that had been frozen
once, twice, or three times. (2) The effect of extraction
state was determined by comparing samples that had been
extracted frozen with those that had been extracted thawed.
(3) The effect of storage temperature was determined by
comparing samples that had been stored for 1 week at 4C,
-20C, and -80C. In order to address these speciﬁc aims,
the following experimental protocol was performed.
Fresh, non-fasting serum samples from 3 healthy vol-
unteers were purchased from PromedDx (Norton, MA).
The blood was collected according to routine venipuncture
protocols by a Food and Drug Administration-regulated
facility, and serum was separated from blood by centrifu-
gation according to routine protocols. The samples were
refrigerated (i.e. never frozen), shipped the day after blood
collection on cold packs, and analyzed within 48 h of
collection, therefore, these samples were considered to be
‘‘fresh.’’
Three batches of serum, each from a different individ-
ual, were tested under all conditions. Three replicates for
each batch within each treatment type were tested, gener-
ating a total of nine samples for each analysis. Each group
of samples was tested under the following conditions: (a)
fresh, never frozen; (b) 1 freeze-thaw cycle; (c) 2 freeze-
thaw cycles; (d) 3 freeze-thaw cycles; (e) frozen once,
lipids extracted directly from frozen sample; (f) 1 freeze-
thaw cycle, frozen again, lipids extracted directly from
frozen sample; (g) stored at 4C for 1 week; (h) 1 freeze-
thaw cycle, stored at -20C for 1 week; and (i) 1 freeze-
thaw cycle, stored at -80C for 1 week. Treatment (a)
samples were extracted as soon as they arrived in the
laboratory. Aliquots of all other samples were frozen as
rapidly as possible. Samples from treatments (e) and (f)
were extracted and analyzed at the same time. Treatments
(g), (h), and (i) samples were extracted and analyzed at the
same time.
Coefﬁcients of variation (CV)’s were calculated as the
standard deviation divided by the mean for each lipid
metabolite measured (e.g. all FA within all lipid classes)
for 5 sample replicates of a fresh serum sample from
Experiment 1. The results are presented in a ﬁgure and
illustrate the level of variability in the measurement of
fresh samples. The effects of number of freeze-thaw cycles
(13 ,2 3 ,3 3) were examined with one-way ANOVA by
comparing samples that were frozen once (treatment b),
twice (treatment c), and three times (treatment d) to fresh
samples (treatment a). Post-hoc analysis by t-test was
employed to determine signiﬁcant differences between
each treatment (b, c, and d) and fresh samples (treatment
a). The effects of extracting frozen compared with thawed
samples (treatments b ? c vs. e ? f) were assessed by
t-test. The temperature effect over 1 week of storage at
4C, -20C, and -80C was compared using one-way
ANOVA. Post-hoc analysis by t-test was used to determine
signiﬁcant differences between storage for 1 week at each
temperature and fresh samples.
2.4 Experiment 2: study design, methods, and statistics
We hypothesized that freezing would affect lipid compo-
sition within lipoproteins separated by density gradient
ultracentrifugation. A blood sample was collected from one
healthy adult after an overnight fast. The Institutional
Review Board of the University of California Davis
approved the study protocol, and written informed consent
was obtained from the subject. The blood was allowed to
clot in the blood collection tube at room temperature for
30 min, and was then centrifuged at 1,600 rpm and 4C for
10 min. The serum was divided into 6 2-ml aliquots within
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12360 min of blood collection. Three of these samples were
kept fresh on ice (e.g. never frozen). The other three
samples were promptly placed in a -80C freezer, kept
frozen for 2 h, and then thawed on ice for 30 min.
The samples were separated at the same time by
sequential ultracentrifugation using a modiﬁcation of the
fast separation micromethod reported by Brousseau et al.
(Brousseau et al. 1993). The centrifugation procedure was
started within 6 h of blood collection and completed on
the same day, using a Sorvall RC-120GX Micro-Ultra-
centrifuge (Sorvall S120-AT2 rotor, 120,000 rpm). To
separate the VLDL, 600 llo fd = 1.006 kg/l NaCl
solution was transferred to each tube, underlain with
1.2 mL of fresh or thawed sample, and submitted to
ultracentrifugation (1 h 23 min, 8C). The top 400 llo f
sample was collected by aspiration as VLDL. To prepare
LDL, the remaining sample was overlain with d =
1.34 kg/l NaCl/NaBr solution, submitted to ultracentrifu-
gation (2 h 5 min, 8C), and the top 400 ll collected by
aspiration. The HDL were prepared similarly, by over-
laying with d = 1.21 kg/l NaCl/NaBr solution, followed
by ultracentrifugation (3 h 30 min, 8C) and aspiration.
All resulting fractions were immediately frozen and stored
at -80C until lipid compositional analysis was per-
formed as described above.
Because there were only two factor levels (fresh and
frozen), a two-sided unpaired t-test was used, with the
assumption that the variances between the two groups were
equal. P values from the unpaired t-test and Bartlett’s test
for variance were calculated for each metabolite in each
lipoprotein fraction separately. When the P-value of the
t-test was \0.05, and the P value of the Bartlett test was
[0.05, the mean metabolite concentration in the fresh vs.
frozen sample after ultracentrifugation was signiﬁcantly
different.
3 Results
The level of variability in the measurement of all of the
metabolites in 5 replicates of a fresh serum sample is
shown in Fig. 1 as the CVs for each metabolite (e.g. each
FA within each lipid class). The CVs were low for all of
the high abundance metabolites, with values as low as 0.01
and 0.02 for many of the key metabolites of biological
relevance in humans (e.g. TG18:1n9, TG total lipid class,
CE16:0, TG16:0, FFA18:1n9, CE20:5n3, CE20:4n6).
Seventy percent of the metabolites measured had CVs
\0.33, 50% of the metabolites had CVs\0.15, and CVs for
the total lipid classes were 0.07, 0.29, 0.08, 0.03, 0.13,
Fig. 1 Coefﬁcients of variation (CV)s for metabolites measured in
fresh serum. The CVs were calculated for each metabolite measured
(e.g. each fatty acid within each lipid class) in 5 replicates of the same
fresh serum sample from Experiment 1. The CVs were plotted in
decreasing order for all metabolites. Low abundance metabolites (e.g.
DG20:4n3, PE14:1n5) had higher CVs whereas high abundance
metabolites (e.g. TG18:1n9, CE16:0) had very low CVs as low as
0.01 and 0.02. This illustrates the high reproducibility of the
analytical method for metabolites of biological signiﬁcance in
humans
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1230.06, and 0.02 for CE, DG, FFA, LY, PC, PE, and TG,
respectively.
A summary of results for Experiment 1 is shown in
Table 1, showing total amounts of each lipid class recov-
ered from fresh serum, and the % of metabolites within each
lipid class that was found to be signiﬁcantly affected by
each treatment. A similar summary of results for Experi-
ment 2 is shown in Table 5, showing total amount of lipid
and total amounts of each lipid class recovered in the
unfractionated serum and within each lipoprotein fraction,
as well as the % of metabolites within each lipid class for
each lipoprotein class that was found to be signiﬁcantly
affected by freezing. The number of metabolites excluded
from statistical analysis based on the stated criteria in Sect.
2.2 for each lipid class was 7, 11, 5, 6, 1, 2, and 4 in CE, DG,
FFA, LY, PC, PE, and TG, respectively. These metabolites
tended to be very low abundance metabolites including
22:2n6, 18:4n3, 20:3n3, 24:6n3, dm16:0, dm18:0,
dm18:1n7, dm18:1n9, t16:1n7, t18:1n9, and t18:2n6.
There were surprisingly few changes in serum lipid
composition that resulted from multiple freeze-thaw cycles
in the present study. In Experiment 1,\1% of metabolites
within each lipid class in samples that had undergone 1, 2,
or 3 freeze-thaw cycles were signiﬁcantly different from
those in fresh samples. Post-hoc analyses were performed
to determine speciﬁc changes between each treatment, and
all comparisons were examined. Shown in Table 2 are only
the metabolites (out of 262) that were signiﬁcantly
different from fresh. DG20:3n9, FFA22:5n3, PE18:0, and
PE20:4n3 were signiﬁcantly decreased after 1 freeze-thaw
cycle. The reductions in DG20:3n9, FFA22:5n3, and
PE20:4n3 were on the order of 50–90%, whereas the
reduction in PE18:0 was only about 9% from fresh.
CE20:2n6 was reduced 50–60% after two and three freeze-
thaw cycles. DG20:3n9, DG20:2n6, LY20:5n3 were also
decreased 30–35% after two freeze-thaw cycles, whereas
LY16:0 and TG22:0 were increased 8% and 38%, respec-
tively, after two freeze-thaw cycles.
The extraction of frozen samples compared with thawed
samples had effects on whole lipid classes, speciﬁcally DG
and PE, which were altered in opposite directions. As
shown in Table 3, 9 out of 262 metabolites were signiﬁ-
cantly affected by extraction state, including increases in
two dimethyl (dm) FA, PCdm18:0 and PCdm18:1n9,
which increased about 40%, and an increase in PE of 27%
when extracted thawed compared with frozen. On the other
hand, DG18:3n6, LY20:4n6, LY22:5n3, PE16:0, and
LYPUFA decreased 10–50%, and DG decreased 26%
when extracted thawed compared with frozen.
The effects of storage temperature for 1 week were
minor, with 0–4% of metabolites signiﬁcantly affected at
Table 1 Total lipid class amounts and % of metabolites signiﬁcantly
different within each lipid class for each treatment in Experiment 1
Lipid class
CE DG FFA LY PC PE TG
Total Amount
a 2,682 34 865 269 1,540 153 317
Fresh vs. Frozen 19
b 04 3 0 06 0
Fresh vs. Frozen 29
b 38 0 6 00 3
Fresh vs. Frozen 39
b 30 0 0 00 0
Extracted frozen vs.
Thawed
b
04 0 1 0 63 0
Fresh vs. 4C
b 34 0 0 00 3
Fresh vs. -20C
b 3 1 9 0 00 00
Fresh vs. -80C
b 04 0 0 30 3
CE cholesteryl ester, DG diacylglycerol, FFA free fatty acids, LY
lysophosphatidylcholine, PC phosphatidylcholine, PE phosphatidyl-
ethanolamine, TG triacylglycerol
a Shown are the total lipid class amounts (nmol fatty acid (FA)/g
serum) for fresh serum from Experiment 1
b Also shown are the % of metabolites within each lipid class that
were signiﬁcantly different for each treatment in Experiment 1: Fresh
vs. frozen once (Frozen 19); fresh vs. frozen twice (Frozen 29); fresh
vs. frozen three times (Frozen 39); extracted frozen vs. extracted
thawed; fresh vs. stored frozen at 4C; fresh vs. stored frozen
at -20C; fresh vs. stored frozen at -80C
Table 2 Metabolites in serum that differed signiﬁcantly when ana-
lyzed fresh vs. frozen once, twice, or three times
Metabolite Mean (SE)
a P-value
Fresh Frozen 19 Fresh vs. Frozen 19
DG20:3n9 0.23 (0.04) 0.11 (0.02) 0.003
FFA22:5n3 0.15 (0.04) 0.07 (0.01) 0.03
PE18:0 27.05 (0.59) 24.57 (0.57) 0.008
PE20:4n3 0.30 (0.08) 0.03 (0.00) 0.006
Fresh Frozen 29 Fresh vs. Frozen 29
CE20:2n6 0.10 (0.03) 0.05 (0.01) 0.048
DG20:3n9 0.23 (0.04) 0.15 (0.02) 0.04
DG20:2n6 0.62 (0.07) 0.41 (0.03) 0.03
LY16:0 39.41 (1.46) 42.81 (1.27) 0.048
LY20:5n3 0.24 (0.02) 0.17 (0.02) 0.04
TG22:0 0.05 (0.01) 0.08 (0.01) 0.03
Fresh Frozen 39 Fresh vs. Frozen 39
CE20:2n6 0.10 (0.03) 0.04 (0.01) 0.03
DG diacylglycerol, FFA free fatty acids, PE phosphatidylethanol-
amine, CE cholesteryl ester, LY lysophosphatidylcholine, TG
triacylglycerol
a Shown are only the signiﬁcant (P\0.05) metabolites (out of 786)
from a one-way ANOVA with mean ± standard error (SE) for each
metabolite, and the P-values for the posthoc analysis (t-test) for fro-
zen once (Frozen 13) relative to fresh, frozen twice (Frozen 23)
relative to fresh, and frozen three times (Frozen 33) relative to fresh.
Fatty acids (FA) and categories of FA are shown as nmol FA/total FA
in lipid class
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1234C, -20C, and -80C in 7 out of 8 lipid classes (CE,
FFA, LY, PC, PE, and TG) and 19% of metabolites
affected by storage at -20C in the DG lipid class
(Table 1). Samples stored at 4C had 20–50% lower con-
centrations of 5 DG metabolites and a 50% decrease in
CE20:2n6 compared with fresh samples (Table 4). Sam-
ples stored at -20C had 50% lower CE20:2n6 and
DG20:3n9 but 45% higher TG22:0 than fresh samples, and
samples stored at -80C had 50% lower DGdm and 3%
lower PCn7 species, whereas TG22:0 was again increased
45% compared with fresh.
In Experiment 2, paired Student’s t-tests were used to
compare metabolites measured in fresh compared with
frozen serum that was separated into VLDL, LDL, and
HDL (Table 5). Within HDL, 10 out of 262 metabolites
were affected by freezing prior to fractionation, including a
21% loss of PC18:2n6 and 37% loss of free cholesterol
(FC) total lipid class, and increases in several LY and
saturated PC species compared with fresh samples
(Table 6). Within LDL from frozen samples, 13 out of 262
metabolites changed signiﬁcantly relative to LDL from
fresh samples, among them a 35% increase in CE, as well
as increases across several long-chain TGPUFA (Table 7).
Within VLDL, 15 out of 262 metabolites were signiﬁcantly
affected, including increases in several LY species,
decreases in several TG species, and a signiﬁcant 36%
decrease in FFA total lipid class (Table 8).
4 Discussion
Variance components in processing and handling are
additive, and can therefore skew results signiﬁcantly.
Whereas past studies examined the effects of storage and
handling conditions on lipid composition measured with
enzymatic kits and immuno-detection, in the current study,
compositional analysis was performed using a platform
combining preparative HPLC and TLC followed by
quantitative GC-FID. Structural changes in lipoprotein
particles and lipid microenvironments that occur during
freeze-thaw cycles and storage at low temperatures likely
impact the quality of enzymatic detection of lipid compo-
sition. However, there may be fewer impacts on lipid
composition itself, as measured by GC-FID, as shown in
this study. Less than 1% of metabolites across 8 classes of
lipids were affected signiﬁcantly by one, two, or three
freeze-thaw cycles.
Storage for 1 week at 4C, -20C, and -80C had only
minor effects on serum lipid composition, with 0–4% of
metabolites affected in most lipid classes. Longer storage
durations, which were not examined in this study, may
Table 3 Metabolites in serum that differed signiﬁcantly when
extracted thawed vs. extracted frozen
Metabolites Mean (SE)
a P-
value
Extract thawed
(b ? c)
Extract frozen
(e ? f)
DG18:3n6 0.34 (0.04) 0.72 (0.17) 0.04
LY20:4n6 5.16 (0.45) 6.68 (0.53) 0.04
LY22:5n3 0.24 (0.03) 0.34 (0.03) 0.02
LYPUFA 25.41 (1.10) 28.55 (0.86) 0.03
PCdm18:0 0.16 (0.03) 0.09 (0.02) 0.046
PCdm18:1n9 0.10 (0.02) 0.06 (0.02) 0.04
PE16:0 11.91 (0.36) 13.05 (0.42) 0.047
DG 60.8 (4.9) 82.5 (7.1) 0.02
PE 182.5 (10.1) 132.5 (8.1) 0.001
DGdiacylglycerol,LYlysophosphatidylcholine,PUFApolyunsaturated
FA, PC phosphatidylcholine, dm dimethyl FA, PE phosphatidyl-
ethanolamine
a Shown are only the signiﬁcant (P\0.05) metabolites (out of 262)
from a t-test with mean ± standard error (SE) for each metabolite,
and the P-values for the t-test. The samples in b and c (extracted
thawed) were combined and compared to the samples in e and f
(extracted frozen). Fatty acids (FA) and categories of FA are shown as
nmol FA/total FA in lipid class (LC), and LC totals are shown as
nmol FA/g serum
Table 4 Metabolites in serum signiﬁcantly affected by storage for 1
week at 4C vs. -20C vs. -80C compared with fresh
Metabolite Mean (SE)
a
4C Fresh P-value
CE20:2n6 0.05 (0.01) 0.10 (0.03) 0.02
DGdm16:0 0.37 (0.05) 0.85 (0.13) 0.02
DG16:1n7 4.25 (0.35) 5.28 (0.23) 0.02
DG20:3n9 0.12 (0.03) 0.23 (0.04) 0.01
DGn7 5.37 (0.42) 6.45 (0.23) 0.02
DGdm 0.37 (0.05) 0.89 (0.14) 0.01
–20C Fresh P-value
CE20:2n6 0.05 (0.00) 0.10 (0.03) 0.02
DG20:3n9 0.12 (0.01) 0.23 (0.04) 0.02
TG22:0 0.09 (0.01) 0.05 (0.01) 0.03
–80C Fresh P-value
DGdm 0.47 (0.07) 0.89 (0.14) 0.04
PCn7 2.25 (0.03) 2.33 (0.03) 0.02
TG22:0 0.09 (0.01) 0.05 (0.01) 0.045
CE cholesterol ester, DG diacylglycerol, PC phosphatidylcholine;
dm dimethyl FA, n7 omega-7 FA, TG triacylglycerol
a Shown are only the signiﬁcant (P\0.05) metabolites (out of 786)
from a one-way ANOVA with mean ± standard error (SE) for each
metabolite, and the P-values for the post-hoc (t-test). Fatty acids (FA)
and categories of FA are shown as nmol FA/total FA in lipid class
(LC), and LC totals are shown as nmol FA/g serum
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123result in more differences. An earlier study found
increasing effects of storage duration from 11 to 27 weeks
(Tiedink and Katan 1989). Further studies are needed to
Table 5 Lipid class totals in serum and fractionated lipoproteins (HDL, LDL, VLDL), and % of metabolites affected by freezing in each lipid
class in Experiment 2
Lipid
class
Serum
a HDL
b LDL
b VLDL
b
Total
amount
Total
amount
% of different
metabolites
Total
amount
% of different
metabolites
Total
amount
% of different
metabolites
CE 3,350 81.7 3 1,768 0 142 0
DG 44 4.4 0 12.1 6 8.6 6
FFA 622 71.2 0 105.5 0 25.8 3
TG 529 10.6 0 165.5 26 94.2 15
LY 271 35.4 6 75.2 0 9.8 9
PC 2,249 49.8 18 1202.6 3 72.4 0
PE 179 18.9 0 109.8 0 9.9 9
FC 1,668 35.7 492.2 68.3
Total lipid 8,912 308 3,931 431
CE cholesterol ester, DG diacylglycerol, FFA free fatty acids, LY lysophosphatidylcholine, PC phosphatidylcholine, PE phosphatidylethanol-
amine, TG triacylglycerol
a Shown are the total amounts of lipid within each lipid class in the serum sample (nmol fatty acid (FA)/g serum), as well as the total amount of
lipid recovered
b Shown are the lipid class totals measured within fractionated serum lipoproteins (nmol FA/g serum), the total amount of lipid recovered in each
lipoprotein fraction, and the % of metabolites that differed in fresh vs. frozen samples within each lipid class. Lipid class totals are shown in nmol
FA/g serum. For free cholesterol (FC), the total amount of lipid is shown as nmol FC/g serum
Table 6 Metabolites in serum HDL that differed signiﬁcantly when
HDL was fractionated from fresh serum vs. serum that was frozen
Metabolite HDL
a
Mean (SE)
Fresh Frozen P-value
CE22:5n3 0.31 (0.02) 0.50 (0.03) 0.01
LY24:1n9 0.05 (0.01) 0.11 (0.01) 0.02
LY18:2n6 15.85 (0.09) 16.24 (0.05) 0.03
PC14:0 0.72 (0.17) 1.60 (0.17) 0.02
PC18:0 15.01 (0.96) 19.03 (0.63) 0.03
PC20:0 0.10 (0.03) 0.24 (0.03) 0.03
PC22:1n9 0.02 (0.02) 0.09 (0.01) 0.02
PC18:2n6 20.27 (1.13) 15.92 (1.04) 0.048
PC20:2n6 0.41 (0.02) 0.32 (0.01) 0.047
FC 35.7 (1.2) 22.3 (1.6) 0.003
CE cholesteryl ester, LY lysophosphatidylcholine, PC phosphatidyl-
choline, FCLC free cholesterol lipid class
a Shown are only the signiﬁcant (P\0.05) metabolites (out of 262)
from an unpaired t-test analysis of fresh vs. frozen within each
lipoprotein fraction with mean ± standard error (SE) for each
metabolite, and the P-values for the t-test. Fatty acids (FA) and cat-
egories of FA are shown as nmol FA/total FA in lipid class (LC), and
LC totals are shown as nmol FA/g serum
Table 7 Metabolites in serum LDL that differed signiﬁcantly when
LDL was fractionated from fresh serum vs. serum that was frozen
Metabolite LDL
a
Mean (SE)
Fresh Frozen P-value
DG15:0 0.78 (0.02) 0.62 (0.03) 0.01
DG20:1n9 0.32 (0.02) 0.23 (0.01) 0.02
PCn6 37.17 (0.07) 38.55 (0.16) 0.01
TG20:1n9 0.22 (0.02) 0.43 (0.01) 0.01
TG20:3n9 0.30 (0.01) 0.33 (0.01) 0.03
TG18:2n6 18.56 (0.14) 19.21 (0.04) 0.04
TG22:5n6 0.13 (0.00) 0.15 (0.00) 0.01
TG22:5n3 0.64 (0.02) 0.752 (0.01) 0.01
TG22:6n3 0.66 (0.02) 0.76 (0.01) 0.03
TGPUFA 26.99 (0.17) 28.25 (0.22) 0.01
TGn3 3.80 (0.11) 4.28 (0.05) 0.04
TGn6 22.90 (0.19) 23.64 (0.17) 0.046
CE 1768 (129) 2383 (45) 0.03
DG diacylglycerol, PC phosphatidylcholine, TG triacylglycerol, n6
omega-6 FA, n3 omega-3 FA, PUFA polyunsaturated FA, CELC
cholesterol ester lipid class
a Shown are only the signiﬁcant (P\0.05) metabolites (out of 262)
from an unpaired t-test analysis of fresh vs. frozen within each
lipoprotein fraction with mean ± standard error (SE) for each
metabolite, and the P-values for the t-test. Fatty acids (FA) and cat-
egories of FA are shown as nmol FA/total FA in lipid class (LC), and
LC totals are shown as nmol FA/g serum
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123examine the effects of temperature with storage durations
longer than 1 week. Even at 1 week, storage at lower
temperatures (-20C and -80C compared with 4C) was
beneﬁcial and reduced alterations to the composition of DG
species in particular, 19% of which were affected by
storage at -20C.
Freezing of samples prior to lipoprotein separation via
density ultracentrifugation signiﬁcantly changed HDL and
LDL cholesterol concentrations as well as VLDL FFA
concentrations. Structural changes in lipoproteins caused
by freezing and thawing may have affected the density
characteristics of particles and/or caused the aggregation of
particles (Castile and Taylor 1999; Cevc and Richardsen
1999). Other possible causes for observed differences in
metabolites resulting from freeze-thaw are enzymatic
hydrolysis and synthesis, enzymatic transfer of lipids
between lipoproteins, and non-enzymatic oxidation. The
hydrolysis of phospholipids, TG, and DG by lipases, and
CE by esterases remaining in the serum, which may be re-
activated after each thawing, may have been involved.
Increased hydrolysis product coupled with decreased
substrate after freezing may be indicative of lipase activity.
For example, in HDL LY18:2n6 increased, whereas
PC18:2n6 decreased after freeze-thaw. Lecithin:cholesterol
acyltransferase associated with HDL, and cholesterol ester
transfer protein associated with HDL, VLDL, and LDL
may have been responsible for the synthesis of new CE
from FC and FFA, and the transfer of lipids between
lipoproteins, respectively. There was a 37% decrease in
HDL FC and a concomitant 36% decrease in VLDL FFA
accompanied by a 35% increase in LDL CE in frozen
compared with fresh serum. The non-enzymatic oxidation
of certain more volatile species (e.g. longer-chain, more
unsaturated FA) may also have been involved. For exam-
ple, several long-chain PUFA species within VLDL TG,
including TG22:4n6 and TG20:4n3, were reduced. How-
ever, these are also very low abundance metabolites, and
thus the reason for the variability in fresh vs. frozen sam-
ples may have been due to the inherent variability in their
measurement as low abundance metabolites rather than due
to oxidation.
The ﬁndings of this study suggest that with careful and
consistent handling, unfractionated serum samples can be
stored for later quantitative lipid analysis with minor
effects on quantitative lipid composition for most of the
biologically relevant lipid species in humans. We suggest
that the prompt storage of the smallest reasonable aliquot
volume at the lowest possible temperature (e.g. -80C) is
preferable for reducing variability in the quantitative
measurement of lipid metabolites introduced by freezing. If
samples need to be thawed in order to divide already frozen
samples into smaller aliquots for several different analyses/
procedures, thawing samples on ice, followed by prompt
redistribution of the larger sample into several smaller
aliquots, and prompt refreezing until analysis should min-
imize any variability that could be introduced by the
additional handling. It must be noted that no samples with
visible crystallization, separation, or discoloration were
included in this study, and therefore, the changes that could
occur to lipid composition in samples that were collected or
handled in such as way as to cause these observable
changes were not tested.
On the other hand, density-based fractionation of lipo-
proteins after freezing was associated with signiﬁcant
changes to HDL and LDL cholesterol concentrations, and
VLDL FFA along with relative increases in LDL TG
metabolites and decreases in VLDL TG metabolites, which
would suggest that the transfer of lipids, and/or physical
changes to the structure of the lipoproteins occurred during
freeze-thaw. Thus, density-based lipoprotein fractionation
of frozen serum samples should be undertaken with caution.
One potential limitation of our study is that in Experi-
ment 2, serum samples from only one donor were studied.
We did not aim to address the question of inter-individual or
Table 8 Metabolites in serum VLDL that differed signiﬁcantly when
VLDL was fractionated from fresh serum vs. serum that was frozen
Metabolite VLDL
a
Mean (SE)
Fresh Frozen P-value
DG24:1n9 0.12 (0.04) 0.29 (0.04) 0.046
DGn3 3.79 (0.22) 4.71 (0.20) 0.03
FFA24:1n9 1.52 (0.17) 2.69 (0.26) 0.03
LY16:1n7 0.68 (0.00) 0.23 (0.05) 0.01
LY20:3n9 0.07 (0.01) 0.12 (0.01) 0.04
LY22:1n9 0.44 (0.12) 1.10 (0.09) 0.01
LY22:5n3 0.42 (0.07) 0.79 (0.08) 0.04
PE14:1n5 0.46 (0.02) 0.28 (0.04) 0.04
PE20:1n9 0.18 (0.01) 0.26 (0.02) 0.04
PE20:3n9 0.31 (0.01) 0.10 (0.01) 0.01
TG20:0 0.03 (0.00) 0.05 (0.00) 0.03
TG20:1n9 0.48 (0.03) 0.23 (0.03) 0.01
TG22:4n6 0.30 (0.01) 0.25 (0.00) 0.01
TG18:4n3 0.13 (0.01) 0.01 (0.00) 0.002
TG20:4n3 0.10 (0.00) 0.01 (0.00) 0
FFA 25.9 (1.4) 16.6 (1.5) 0.012
DG diacylglycerol, FFA free fatty acids, LY lysophosphatidylcholine,
PE phosphatidylethanolamine, TG triacylglycerol, n3 omega-3 FA
a Shown are only the signiﬁcant (P\0.05) metabolites (out of 262)
from an unpaired t-test analysis of fresh vs. frozen within each
lipoprotein fraction with mean ± standard error (SE) for each
metabolite, and the P-values for the t-test. Fatty acids (FA) and cat-
egories of FA are shown in nmol FA/total FA lipid class (LC), and
LC totals are shown in nmol FA/g serum
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123biological variability among individuals, which is a topic of
great interest in the clinical research community, and which
has been studied previously (Ruhli et al. 2008; Zivkovic
et al. 2008). Instead, to address the methodological question
of how freeze-thaw affects sample stability with regard to
quantitative lipid analysis following lipoprotein fraction-
ation, we analyzed the serum sample in triplicate.
5 Concluding remarks
Important clinical samples often need to be stored prior to
analysis. It is also often the case that additional analyses
need to be performed on existing samples that represent a
precious resource. Samples may be from especially vul-
nerable populations or may represent unique opportunities
that would be difﬁcult to replicate. In all of these situa-
tions, the proper storage and handling of samples is
paramount to retaining their informativeness. The ﬁndings
of this study suggest that if samples are handled with
care, it is possible to effectively eliminate the potential
variability introduced by handling and storage for quan-
titative lipid compositional analysis in unfractionated
serum for the majority of metabolites that are of bio-
logical relevance in humans (e.g. the high abundance
metabolites). However, freezing prior to density-based
fractionation does introduce signiﬁcant variability partic-
ularly in HDL and LDL cholesterol as well as LDL and
VLDL TG concentrations.
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